Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids

Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids

J Borensztajn, GS Getz and TJ Kotlar
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611.

Rat lymph chylomicrons were treated with rat heparin-releasable hepatic lipase (HL) or with bovine milk lipoprotein lipase (LPL). The ability of the resulting particles to be taken up by the liver in vivo was assessed following their infusion into the portal vein of partially hepatectomized animals. The following observations were made: a) the rate of phospholipid depletion, relative to the rate of triglyceride hydrolysis, induced by HL was two- to threefold higher than that observed for LPL; b) the depletion of at least 57% of phospholipids from the surface of HL-treated chylomicrons caused no major alterations in the apoprotein profile of the particles; c) for the same extent of triglyceride hydrolysis, HL-treated chylomicrons were taken up by liver at a rate significantly higher (P less than 0.005) than LPL-treated particles; d) the liver uptake of HL-treated chylomicrons was competitively inhibited by endogenously generated chylomicron remnants, indicating that these two types of lipoproteins share the same process of recognition and uptake by liver cells. It is concluded that the in vivo changes in phospholipid content, or composition, on the surface of chylomicrons during their transformation into remnants, modulate the differentiation of these two particles by the hepatic remnant receptor.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

G. M. Spitsen, S. Dueland, S. K. Krisans, C. J. Slattery, J. H. Miyake, and R. A. Davis
In nonhepatic cells, cholesterol 7{alpha}-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux, and homeostasis
J. Lipid Res., August 1, 2000; 41(8): 1347 - 1355.
[Abstract] [Full Text]

E. H. Harrison
Lipases and Carboxylesterases: Possible Roles in the Hepatic Utilization of Vitamin A
J. Nutr., February 1, 2000; 130(2): 340 - 340.
[Abstract] [Full Text]

S. E. Crawford and J. Borensztajn
Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway
J. Lipid Res., May 1, 1999; 40(5): 797 - 805.
[Abstract] [Full Text]

H. Jansen, G. Chu, C. Ehnholm, J. Dallongeville, V. Nicaud, and P. J. Talmud
The T Allele of the Hepatic Lipase Promoter Variant C-480T Is Associated With Increased Fasting Lipids and HDL and Increased Preprandial and Postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 303 - 308.
[Abstract] [Full Text] [PDF]

M. Komaromy, S. Azhar, and A. D. Cooper
Chinese Hamster Ovary Cells Expressing a Cell Surface-anchored Form of Hepatic Lipase. CHARACTERIZATION OF LOW DENSITY LIPOPROTEIN AND CHYLOMICRON REMNANT UPTAKE AND SELECTIVE UPTAKE OF HIGH DENSITY LIPOPROTEIN-CHOLESTERYL ESTER
J. Biol. Chem., July 12, 1996; 271(28): 16906 - 16914.
[Abstract] [Full Text] [PDF]

H. Bernardes-Silva, O. Toffoletto, L. A. Bortolotto, M. C.M. Latrilha, E. M. Krieger, F. Pileggi, and R. C. Maranhao
Malignant Hypertension Is Accompanied by Marked Alterations in Chylomicron Metabolism
Hypertension, December 1, 1995; 26(6): 1207 - 1210.
[Abstract] [Full Text]

H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, S. Lund-Katz, and M. C. Phillips
Lipid Binding-induced Conformational Change in Human Apolipoprotein E. EVIDENCE FOR TWO LIPID-BOUND STATES ON SPHERICAL PARTICLES
J. Biol. Chem., October 26, 2001; 276(44): 40949 - 40954.
[Abstract] [Full Text] [PDF]